What drug classes act on Neisseria meningitidis serogroup C polysaccharide capsule?

Drug classes acting on Neisseria meningitidis serogroup C polysaccharide capsule include Meningococcal conjugate vaccine, Conjugate vaccine.

Neisseria meningitidis serogroup C polysaccharide capsule — Drug Target

7 drugs 4 marketed 3 in Phase 3

All drugs that target Neisseria meningitidis serogroup C polysaccharide capsule — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Meningococcal conjugate vaccine · Conjugate vaccine

Marketed (4)

NeisVac-C® · Merck Sharp & Dohme LLC · Meningococcal conjugate vaccine · Immunology / Infectious Disease
NeisVac-C is a meningococcal serogroup C conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C.
Meningococcal C · Wyeth is now a wholly owned subsidiary of Pfizer · Conjugate vaccine · Immunology / Infectious Disease
Meningococcal C conjugate vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C polysaccharide capsule.
NeisVac C vaccine (12mth) · University of British Columbia · Meningococcal conjugate vaccine · Immunology / Infectious Disease
NeisVac C is a conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C polysaccharide capsule.
Meningitec® · GlaxoSmithKline · Conjugate vaccine · Immunology / Infectious Disease
Meningitec is a conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C.

Phase 3 pipeline (3)

Neis-Vac-C · GlaxoSmithKline · Conjugate vaccine · Immunology / Infectious Disease
Neis-Vac-C is a meningococcal serogroup C conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C.
NeisVac-CTM · GlaxoSmithKline · Meningococcal conjugate vaccine · Immunology / Infectious Disease
NeisVac-C is a meningococcal C conjugate vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup C.
MCC-CRM · MCM Vaccines B.V. · Conjugate vaccine · Immunology / Infectious Disease
MCC-CRM is a meningococcal C conjugate vaccine that stimulates immune responses against Neisseria meningitidis serogroup C through conjugation of the polysaccharide capsule to a carrier protein.